November 16, 2021 Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference read more
November 4, 2021 Quanterix Corporation Releases Operating Results for Third Quarter of 2021 read more
October 11, 2021 Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease read more
Scientific American February 8, 2021 Detecting Alzheimer’s Gets Easier with a Simple Blood Test read more
March 22, 2021 Ultrasensitive quantification of plasma biomarkers is shaping the future of care for Alzheimer’s disease read more
August 14, 2020 Quanterix Simoa® Technology Powered Nearly 60 Posters And Presentations At Alzheimer’s Association International Conference (AAIC) 2020 read more